Matthew B. Boxer
Fondateur chez Veralox Therapeutics, Inc.
Profil
Matthew B.
Boxer has founded Veralox Therapeutics, Inc. in 2017, where he holds the title of Chief Operating Officer & Director.
He was also a Vice President & Head-Translational Medicine at Rebus Holdings, Inc. in 2017.
Dr. Boxer holds a doctorate from The University of Chicago and an undergraduate degree from the University of Vermont.
Postes actifs de Matthew B. Boxer
| Sociétés | Poste | Début |
|---|---|---|
Veralox Therapeutics, Inc.
 Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Fondateur | 01/01/2017 |
Anciens postes connus de Matthew B. Boxer
| Sociétés | Poste | Fin |
|---|---|---|
| REBUS HOLDINGS, INC. | Corporate Officer/Principal | 01/12/2017 |
Formation de Matthew B. Boxer
| The University of Chicago | Doctorate Degree |
| University of Vermont | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| REBUS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Health Technology |
